Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

1.62USD
24 Sep 2018
Change (% chg)

-- (--)
Prev Close
$1.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
77,103
52-wk High
$8.65
52-wk Low
$1.36

Chart for

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $263.85
Shares Outstanding(Mil.): 163.88
Dividend: --
Yield (%): --

Financials

  CRIS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.50 -- --
ROI: -124.16 1.79 14.61
ROE: -250.87 3.28 16.33

BRIEF-Curis Files For Mixed Shelf Of Upto $200 Mln

* CURIS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: (https://bit.ly/2rkihf5) Further company coverage:

03 May 2018

BRIEF-Curis Reports Q1 Loss Per Share $0.07

* Q1 EARNINGS PER SHARE VIEW $-0.09 -- THOMSON REUTERS I/B/E/S

03 May 2018

Earnings vs. Estimates